Bioventix PLC (LON:BVXP – Get Free Report)’s stock price hit a new 52-week low during trading on Thursday . The company traded as low as GBX 2,905 ($36.32) and last traded at GBX 2,998 ($37.48), with a volume of 7773 shares trading hands. The stock had previously closed at GBX 3,025 ($37.82).
Bioventix Stock Down 0.9 %
The business’s fifty day moving average price is GBX 3,316.26 and its 200 day moving average price is GBX 3,751.43. The firm has a market capitalization of £156.50 million, a PE ratio of 1,839.26 and a beta of 0.35.
Insider Buying and Selling at Bioventix
In other news, insider Bruce Hiscock acquired 24 shares of the company’s stock in a transaction on Friday, November 22nd. The shares were bought at an average cost of GBX 3,822 ($47.78) per share, with a total value of £917.28 ($1,146.74). 8.02% of the stock is owned by company insiders.
About Bioventix
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Featured Articles
- Five stocks we like better than Bioventix
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- Earnings Per Share Calculator: How to Calculate EPS
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- How to Most Effectively Use the MarketBeat Earnings Screener
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
